Gastrointestinal tract in liver disease: which organ is sick?
Authors:
- Kristina NormanKNKristina Norman
- Matthias PirlichMPMatthias Pirlich
- 1 September 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Clinical Nutrition and Metabolic Care
- Vol. 11 (5) , 613-619
Abstract
This article gives an overview of the several morphological and functional alterations in the gastrointestinal tract that occur in liver disease and their systemic impact. Recent endoscopic studies have revealed similar mucosal alterations in the upper gastrointestinal as well as the colon that include inflammatory-like changes and vascular lesions. Gut-barrier integrity is consequently impaired. There is an evidence that bacterial translocation with subsequent endotoxaemia provokes an inflammatory response that might trigger the cachexia syndrome in liver disease. Novel therapeutic approaches that address gut-barrier function such as supplementation with insulin-like growth factor or synbiotics have shown promising results. There are various alterations of the gastrointestinal tract in liver disease and portal hypertension, which might be less clinically overt than the cardinal potentially life-threatening features, ascites and oesophageal varices. However, these alterations, for example gut-barrier dysfunction and alterations of gut flora (microbiota) have immense impact on the portal enteropathy, as they both contribute to the systemic inflammation in liver cirrhosis, which is considered a risk factor for infections as well as the development of cachexia.Keywords
This publication has 57 references indexed in Scilit:
- Inflammation: a way to understanding the evolution of portal hypertensionTheoretical Biology and Medical Modelling, 2007
- Insulin-like growth factor I improves intestinal barrier function in cirrhotic ratsGut, 2006
- Prehepatic portal hypertension produces increased mast cell density in the small bowel and in mesenteric lymph nodes in the ratJournal of Gastroenterology and Hepatology, 2005
- Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascitesThe Lancet, 2004
- Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis: amelioration with norfloxacinJournal of Hepatology, 2004
- Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangementHepatology, 2003
- Cachexia in liver cirrhosisInternational Journal of Cardiology, 2002
- Bacterial translocation of enteric organisms in patients with cirrhosisJournal of Hepatology, 2001
- Small bowel bacterial overgrowth in patients with alcoholic cirrhosisDigestive Diseases and Sciences, 1995
- Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excessJournal of Hepatology, 1987